Therapy: Off-label biologics use and infection risk-the great unknown
Nat Rev Rheumatol
.
2011 Oct 11;7(12):685-6.
doi: 10.1038/nrrheum.2011.154.
Authors
Kevin L Winthrop
,
Josef S Smolen
PMID:
21989283
DOI:
10.1038/nrrheum.2011.154
No abstract available
Publication types
News
MeSH terms
Autoimmune Diseases / drug therapy*
Humans
Immunologic Factors / adverse effects*
Infections / chemically induced*
Off-Label Use*
Substances
Immunologic Factors